| Dr Aditi Mulgund Stanton, MD | |
|
3301 Mercy Health Blvd Ste 445, Cincinnati, OH 45211-1106 | |
| (561) 389-7300 | |
| Not Available |
| Full Name | Dr Aditi Mulgund Stanton |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 9 Years |
| Location | 3301 Mercy Health Blvd Ste 445, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578950309 | NPI | - | NPPES |
| 1578950309 | Other | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 35.141891 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health - West Hospital | Cincinnati, OH | Hospital |
| Christ Hospital | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gcga Physicians Inc. | 4284618224 | 72 |
News Archive
Researchers at Albert Einstein College of Medicine of Yeshiva University have been awarded $600,000 from the American Diabetes Association to study the effect of resveratrol, a chemical compound most notably found in red wine and grapes, on impaired glucose tolerance in older adults.
Their findings - published in the latest edition of Circulation Research, online July 8 - may lead to a gene therapy alternative to calcium channel blockers and their sometimes severe side effects, but also further interest in the development of gene therapies unique - as in this case - to one particular organ.
A new approach to 'prime' the tumor environment may improve how effective chemotherapy is for pancreatic ductal adenocarcinoma, one of the most aggressive forms of pancreatic cancer.
In a research paper recently uploaded to the preprint server medRxiv* by Prof. Gwenaëlle Douaud et al. (June 15th, 2021), participants that had taken part in a brain study prior to the onset of the COVID-19 pandemic were invited back for a series of follow-up tests, revealing significant losses of grey matter surrounding the olfactory and gustatory system in those that had been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
› Verified 8 days ago
| Entity Name | Gcga Physicians Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790851095 PECOS PAC ID: 4284618224 Enrollment ID: O20040616000950 |
News Archive
Researchers at Albert Einstein College of Medicine of Yeshiva University have been awarded $600,000 from the American Diabetes Association to study the effect of resveratrol, a chemical compound most notably found in red wine and grapes, on impaired glucose tolerance in older adults.
Their findings - published in the latest edition of Circulation Research, online July 8 - may lead to a gene therapy alternative to calcium channel blockers and their sometimes severe side effects, but also further interest in the development of gene therapies unique - as in this case - to one particular organ.
A new approach to 'prime' the tumor environment may improve how effective chemotherapy is for pancreatic ductal adenocarcinoma, one of the most aggressive forms of pancreatic cancer.
In a research paper recently uploaded to the preprint server medRxiv* by Prof. Gwenaëlle Douaud et al. (June 15th, 2021), participants that had taken part in a brain study prior to the onset of the COVID-19 pandemic were invited back for a series of follow-up tests, revealing significant losses of grey matter surrounding the olfactory and gustatory system in those that had been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aditi Mulgund Stanton, MD 3301 Mercy Health Blvd Ste 445, Cincinnati, OH 45211-1106 Ph: () - | Dr Aditi Mulgund Stanton, MD 3301 Mercy Health Blvd Ste 445, Cincinnati, OH 45211-1106 Ph: (561) 389-7300 |
News Archive
Researchers at Albert Einstein College of Medicine of Yeshiva University have been awarded $600,000 from the American Diabetes Association to study the effect of resveratrol, a chemical compound most notably found in red wine and grapes, on impaired glucose tolerance in older adults.
Their findings - published in the latest edition of Circulation Research, online July 8 - may lead to a gene therapy alternative to calcium channel blockers and their sometimes severe side effects, but also further interest in the development of gene therapies unique - as in this case - to one particular organ.
A new approach to 'prime' the tumor environment may improve how effective chemotherapy is for pancreatic ductal adenocarcinoma, one of the most aggressive forms of pancreatic cancer.
In a research paper recently uploaded to the preprint server medRxiv* by Prof. Gwenaëlle Douaud et al. (June 15th, 2021), participants that had taken part in a brain study prior to the onset of the COVID-19 pandemic were invited back for a series of follow-up tests, revealing significant losses of grey matter surrounding the olfactory and gustatory system in those that had been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
› Verified 8 days ago
Moises Arturo Huaman Joo, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman Street, Cincinnati, OH 45219 Phone: 513-584-6977 Fax: 513-584-4281 | |
Dr. Kiranmayee Lanka, M.D., M.P.H Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2123 Auburn Ave, Suite 401, Cincinnati, OH 45219 Phone: 513-241-5489 Fax: 513-241-5490 | |
Dr. Saurabh Chandra, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-558-1000 | |
Gretchen Suarez, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10500 Montgomery Rd, Cincinnati, OH 45242 Phone: 513-865-2246 Fax: 513-865-5596 | |
Dr. Andrew Michael Espinal, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 4777 E Galbraith Rd, Cincinnati, OH 45236 Phone: 513-686-3000 | |
Sorina M Macavei, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 463 Ohio Pike, Suite 300, Cincinnati, OH 45255 Phone: 513-528-5600 Fax: 513-528-9716 | |
Helen K Koselka, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 3219 Clifton Ave, Suite 100, Cincinnati, OH 45220 Phone: 513-528-5600 Fax: 513-528-9716 |